Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type

Respiratory Medicine

Volumn 108, Issue 10, 2014, Pages 1542-1548

  Johnson, C ^a   Connors, G R ^b   Oaks, J ^c   Han, S ^d,e   Truong, A ^f   Richardson, B ^a   Lechtzin, N ^a   Mammen, A L ^a,g   Casciola Rosen, L ^a   Christopher Stine, L ^a   Danoff, S K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PC   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f EMORY UNIVERSITY HOSPITAL   (United States)

^g NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Dermatomyositis; IL; Polymyositis Antisynthetase syndrome

Indexed keywords

ANTIBODY; ANTISYNTHETASE ANTIBODY; EJ ANTIBODY; JO 1 ANTIBODY; OJ ANTIBODY; PL 12 ANTIBODY; PL 7 ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ADULT; AFRICAN AMERICAN; ANTISYNTHETASE SYNDROME; ARTICLE; CAUCASIAN; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FORCED VITAL CAPACITY; HUMAN; IMMUNOPATHOLOGY; INTERSTITIAL LUNG DISEASE; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PHENOTYPE; RACE DIFFERENCE; AGED; CASE CONTROL STUDY; IMMUNOLOGY; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY; VITAL CAPACITY;

ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84908351508     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.09.003     Document Type: Article

References (31)

1. G. Ahlstrom, L.G. Gunnarsson, P. Leissner, and P.O. Sjoden Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county Neuroepidemiology 12 1993 262 269
2. A. Imbert-Masseau, M. Hamidou, C. Agard, J.Y. Grolleau, and P. Cherin Antisynthetase syndrome Jt Bone Spine 70 2003 161 168
3. C. Marguerie, C.C. Bunn, and H.L. Beynon Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes Q J Med 77 1990 1019 1038
4. Antsynthetase syndrome 2001 at http://www.orpha.net/data/patho/Pro/en/Antisynthetase-FRenPro8611.pdf
5. J.M. Grau, O. Miro, and E. Pedrol Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement J Rheumatol 23 1996 1921 1926
6. T.J. Richards, A. Eggebeen, and K. Gibson Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease Arthritis Rheum 60 2009 2183 2192
7. E.L. Arsura, and A.S. Greenberg Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis Semin Arthritis Rheum 18 1988 29 37
8. D. Vazquez-Abad, and N.F. Rothfield Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis Arthritis Rheum 39 1996 292 296
9. N. Hayashi, M. Koshiba, and K. Nishimura Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period Mod Rheumatol Jpn Rheum Assoc 18 2008 153 160
10. M. Satoh, E.K. Chan, and L.A. Ho Prevalence and sociodemographic correlates of antinuclear antibodies in the United States Arthritis Rheum 64 2012 2319 2327
11. F.C. Arnett, T.J. Hirsch, W.B. Bias, M. Nishikai, and M. Reichlin The Jo-1 antibody system in myositis: relationships to clinical features and HLA J Rheumatol 8 1981 925 930
12. T. Furuya, M. Hakoda, and N. Tsuchiya Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy J Rheumatol 31 2004 1768 1774
13. W.W. Douglas, H.D. Tazelaar, and T.E. Hartman Polymyositis-dermatomyositis-associated interstitial lung disease Am J Respir Crit Care Med 164 2001 1182 1185
14. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (second of two parts) N Engl J Med 292 1975 403 407
15. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 1975 344 347
16. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
17. N. Macintyre, R.O. Crapo, and G. Viegi Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur Respir J 26 2005 720 735
18. J.G. Goldin, D.A. Lynch, and D.C. Strollo High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease Chest 134 2008 358 367
19. D.A. Lynch, J.D. Godwin, and S. Safrin High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis Am J Respir Crit Care Med 172 2005 488 493
20. S. Bernatsky, L. Joseph, and C.A. Pineau Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences Ann Rheum Dis 68 2009 1192 1196
21. L.G. Rider, M. Shah, and G. Mamyrova The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies Medicine 92 2013 223 243
22. A.C. Gelber, R.L. Manno, and A.A. Shah Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the johns hopkins scleroderma center and review of the literature Medicine 92 2013 191 205
23. M. Fathi, J. Vikgren, and M. Boijsen Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology Arthritis Rheum 59 2008 677 685
24. B. Hervier, and O. Benveniste Clinical heterogeneity and outcomes of antisynthetase syndrome Curr Rheumatol Rep 15 2013 349
25. M. Kalluri, and C.V. Oddis Pulmonary manifestations of the idiopathic inflammatory myopathies Clin Chest Med 31 2010 501 512
26. D. Tansey, A.U. Wells, and T.V. Colby Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis Histopathology 44 2004 585 596
27. S. Hayashi, M. Tanaka, and H. Kobayashi High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis J Rheumatol 35 2008 260 269
28. E.H. Kang, E.B. Lee, and K.C. Shin Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis Rheumatol Oxf Engl 44 2005 1282 1286
29. I. Marie, E. Hachulla, and P. Cherin Interstitial lung disease in polymyositis and dermatomyositis Arthritis Rheum 47 2002 614 622
30. T. Saeki, E. Suzuki, and T. Watanabe Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM) Ryumachi 34 1994 16 21
31. S. Ye, X.X. Chen, and X.Y. Lu Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study Clin Rheumatol 26 2007 1647 1654